JG
VNDA icon

Joel Greenblatt’s Vanda Pharmaceuticals VNDA Stock Holding History

Joel Greenblatt’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-18,994
Closed -$298K – 1250
2021
Q4 		$298K Buy
18,994
+4,695
+33% +$81.8K 0.01% 945
2021
Q3 		$245K Sell
14,299
-583
-4% -$10.2K 0.01% 906
2021
Q2 		$320K Buy
14,882
+4,664
+46% +$83.5K 0.01% 824
2021
Q1 		$153K Sell
10,218
-3,839
-27% -$62.1K 0.01% 964
2020
Q4 		$185K Sell
14,057
-19,104
-58% -$230K 0.01% 943
2020
Q3 		$320K Sell
33,161
-47,369
-59% -$506K 0.01% 828
2020
Q2 		$921K Sell
80,530
-77,054
-49% -$872K 0.03% 579
2020
Q1 		$1.63M Sell
157,584
-3,608
-2% -$44.7K 0.05% 449
2019
Q4 		$2.65M Sell
161,192
-1,422
-0.9% -$21.5K 0.05% 396
2019
Q3 		$2.16M Buy
162,614
+127,061
+357% +$1.77M 0.04% 441
2019
Q2 		$501K Sell
35,553
-8,729
-20% -$139K 0.01% 802
2019
Q1 		$815K Buy
44,282
+19,818
+81% +$452K 0.01% 707
2018
Q4 		$639K Buy
+24,464
New +$575K 0.01% 720
2017
Q4 		– Sell
-142,159
Closed -$2.54M – 1070
2017
Q3 		$2.54M Sell
142,159
-31,764
-18% -$532K 0.04% 476
2017
Q2 		$2.83M Buy
173,923
+5,970
+4% +$86K 0.04% 462
2017
Q1 		$2.35M Buy
167,953
+107,736
+179% +$1.54M 0.03% 526
2016
Q4 		$960K Buy
60,217
+32,973
+121% +$530K 0.01% 627
2016
Q3 		$453K Buy
27,244
+12,940
+90% +$174K 0.01% 729
2016
Q2 		$160K Buy
+14,304
New +$139K ﹤0.01% 901

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Joel Greenblatt's VNDA Position: Q1 2022 in Review

Joel Greenblatt sold out of Vanda Pharmaceuticals (VNDA) in Q1 2022, closing a stake of 18,994 shares — an estimated $298K sold.

Joel Greenblatt first reported a position in VNDA in Q2 2016 and held it in 19 quarters. The position peaked at $2.83M in Q2 2017. 188 funds tracked by Wall St. Rank hold VNDA as of Q1 2022.

  • Joel Greenblatt reported no remaining Vanda Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Joel Greenblatt sold 18,994 Vanda Pharmaceuticals shares in Q1 2022, an estimated $298K.
  • Joel Greenblatt first reported a position in Vanda Pharmaceuticals in Q2 2016 and held it in 19 quarters.
  • Joel Greenblatt's Vanda Pharmaceuticals position peaked at $2.83M in Q2 2017.
  • 188 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2022.

Based on Gotham Asset Management's 13F filing for Q1 2022, filed 16 May 2022.